Several risk factors, including the number of transplanted CD34-positive cells, disease state, drug-induced toxicity, GvHD, infections, and an impaired bone marrow microenvironment have been reported to be associated with the occurrence of poor graft function [2, 3, 5–9]. This evidence concerns the gene CD34 and graft versus host disease.